Berlin keynote details Eos SENOLYTIX's pre-clinical results with mitochondrial-targeted geropeptide on healthspan and lifespan.
As its CEO takes the stage in Berlin, the company opens a window on its longest-lived treated mice – and the data behind them ...
Insilico Medicine nominates ISM9546, an oral VAV1 degrader designed with generative AI, as a preclinical candidate for ...
As pharma shops for de-risked science, venture money is moving later and concentrating in fewer, bigger bets – our report ...
Avaí Bio and Austrianova began work with Ospedale San Raffaele on protecting lab-grown insulin cells from the immune system.
Rona Therapeutics grants Roche worldwide rights to an ALK7-silencing candidate, with up to $1.06b in further milestones on ...
KAUST and Oxford researchers used a transistor-based sensor to read three forms of alpha-synuclein, reaching 90.9% accuracy ...
Nature Biotechnology paper offers a better way to judge models that predict gene effects. Shift plans to use it to hunt for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results